Rep. reintroduces clinical trial transparency bill

06/11/2013 | PharmaLive.com

Rep. Tom Reed, R-N.Y., reintroduced a bill that would require publicly funded research results to be reported to ClinicalTrials.gov whether the outcome is positive or negative. Researchers who fail to comply would be ineligible for future grants. "It's vitally important all trial results are shared so that we might better understand the results to provide better care and advance our shared goal of finding a cure," Reed said, emphasizing the bill's importance for cancer research.

View Full Article in:

PharmaLive.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD